RN
RenaissanceRe
RNR · NYSE
$324.05 +0.47% (+$1.52)
1M +1.90%
Market Cap $13.4B
P/E Ratio 5.09x
Div. Yield 0.50%
ROE 22.68%
Bulios Fair Price
$409.52
26.4% upside
Current Price
$324.05
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RNR is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
97 /100
Cheap P/E 5.09x
P/S 1.26x
P/B 1.13x
Growth
100 /100
Growing Rev. growth 36.17%
Book val. growth 29.66%
EPS growth N/A
Profitability
99 /100
Strong Net margin 24.71%
Op. margin 38.77%
Gross margin N/A
Quality
100 /100
Excellent ROE 22.68%
ROA 4.77%
Asset turnover 0.19x
Debt
100 /100
Low Current ratio 1.76x
Debt/Equity N/A
Int. coverage N/A
Stability
14 /100
Unstable Beta 0.17x
Rev. volatility 36.58%
EPS volatility 174.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RNR
Online
Sector
Financial Services
Industry
Insurance - Reinsurance
CEO
Kevin J. O'Donnell
Employees
1,040
Headquarters
Pembroke
Upcoming events
15 SEP
Ex-Dividend
Ex-dividend date
30 SEP
Dividend Payment
Payment date
03 NOV
Earnings
Upcoming earnings report